[1] 国家药典委员会. 中华人民共和国药典[M]. 北京:化学工业出版社, 2015:348. [2] Lu Y, Qian RQ, Xiao J, et al. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and Th17 cells and inducing apoptosis of effect or T cells[J]. Scientific Reports, 2015, 5:9022. [3] Lu Y, Qian R, Xiao J, et al. Kirenol, a compound from Herba Siegesbeckiae, induces apoptosis in human chronic myeloid leukemia K562 cells[J]. Pharmazie, 2014, 69(2):148-153. [4] Hwang JH, Kim JD. Inhibitory effects of Siegesbeckiae herba extract on angiogenesis and adipogenesis[J]. Biotechnology and Bioprocess Engineering, 2011, 1(16):144-152. [5] 柴明艳. 车前草内生真菌的分离及抑菌活性测定[J]. 江苏农业科学, 2016, 44(1):353-356. [6] 周邦靖. 常用中药的抗菌作用及其测定方法[M]. 重庆:科学技术文献出版社重庆分社, 1987:100-299. [7] Marchesi JR, Sato T, Weightman AJ, et al. Design and evaluation of useful bacterium-specific PCR primers that amplify genes coding for bacterial 16S rRNA[J]. Applied and Environmental Microbiology, 1998, 64(2):795-799. [8] 史应武, 娄恺, 李春. 植物内生菌在生物防治中的应用[J]. 微生物学杂志, 2009, 11(6):61-64. [9] 黄午阳. 植物内生真菌的抗菌活性研究[J]. 南京中医药大学学报, 2005, 21(1):24-26. [10] Laubach CA. Studies on aerobic spore-bearing non-pathogenic bacteria partⅡ. Spore-bearing organisms in water[J]. Journal of Bacterial, 1916, 1(5):506-512. [11] Shida O, Takagi H, Kadowaki K, et al. Proposal for two new genera, Brevibacillus gen. nov. and Aneurinibacillus gen. Nov[J]. International Journal of Systematic and Evolutionary Microbiology, 1996, 46(4):939-946. [12] 陈潺, 陈升富, 王建宇, 等. 侧孢短芽孢杆菌的应用研究进展[J]. 山东农业科学, 2015, 47(2):149-156. [13] Djukic M, Poehlein A, Thürmer A, et al. Genome sequence of Bre- vibacillus laterosporus LMG 15441, a pathogen of invertebrates[J]. Journal of Bacterial, 2011, 193(19):5535-5536. [14] Sharma V, Singh PK, Midha S, et al. Genome sequence of Brevibacillus laterosporus strain GI-9[J]. Journal of Bacterial, 2012, 194(5):1279. [15] Hong HA, Duc LH, Cutting SM. The use of bacterial spore formers as probiotics[J]. FEMS Microbiology Rev, 2005, 29(4):813-835. [16] Barsby T, Kelly MT, Andersen RJ. Tupuseleiamides and basiliskamides, new acyldipeptides and antifungal polyketides produced in culture by a Bacillus laterosporus isolate obtained from a tropical marine habitat[J]. Journal of Natural Products, 2002, 65(10):1447-1451. [17] Desjardine K, Pereira A, Wright H, et al. Tauramamide, a lipopeptide antibiotic produced in culture by Brevibacillus laterosporus isolated from a marine habitat:Structure elucidation and synthesis[J]. Journal of Natural Products, 2007, 70(12):1850-1853. [18] Yang X, Huang E, Yuan CH. Isolation and structural elucidation of Brevibacillin, an antimicrobial lipopeptide from Brevibacillus laterosporus that combats drug-resistant Gram-positive bacteria[J]. Applied and Environmental Microbiology, 2016, 82(9):2763-2772. |